These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 881153)

  • 1. [Requirements on the production and testing of sera and vaccines].
    Bonin O
    Fortschr Med; 1977 Jun; 95(23):1541-8. PubMed ID: 881153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring veterinary vaccines for contaminating viruses.
    Ottiger HP
    Dev Biol (Basel); 2006; 126():309-19; discussion 327. PubMed ID: 17058507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
    Jungbäck C; Motitschke A
    Biologicals; 2010 May; 38(3):362-5. PubMed ID: 20335053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Principles of laboratory studies on sera and vaccines].
    Galazka A
    Pol Tyg Lek; 1968 Oct; 23(41):1575-9. PubMed ID: 5702420
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of product batches (before and after registration). The German approach.
    Jungbäck C
    Dev Biol Stand; 1992; 79():171-4. PubMed ID: 1286753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHO Expert Committee on Biological Standardization. Forty-sixth Report.
    World Health Organ Tech Rep Ser; 1998; 872():i-vii, 1-90. PubMed ID: 9615608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endotoxic contamination of biological products (ribosomal vaccines, viral vaccines and interferon)].
    Fumarola D; Panaro A; Palma R; Mazzone A
    G Batteriol Virol Immunol; 1979; 72(1-6):72-7. PubMed ID: 95449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. License requirements and agents licensed.
    Price RJ; Espeseth DA
    J Am Vet Med Assoc; 1972 Feb; 160(4):507-9. PubMed ID: 5063983
    [No Abstract]   [Full Text] [Related]  

  • 9. Viral safety of biological products in WHO policy.
    Grachev VP
    Dev Biol Stand; 1991; 75():241-6. PubMed ID: 1794628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for sterility testing of oral bacterial vaccines.
    Mebel S; Thilo W; Rustenbach S; Koch H; Pluschkat H
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):35-9. PubMed ID: 4216251
    [No Abstract]   [Full Text] [Related]  

  • 11. Assuring the quality and safety of vaccines: regulatory licensing and batch release.
    Griffiths E; Knezevic I
    Methods Mol Med; 2003; 87():353-76. PubMed ID: 12958467
    [No Abstract]   [Full Text] [Related]  

  • 12. [Theoretical bases and experimental verifications in using cell cultures in developing new quality assessment and standardization criteria for medical immunobiological preparations].
    Chervonskaia GP; Kravchenko AT
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):84-91. PubMed ID: 3529756
    [No Abstract]   [Full Text] [Related]  

  • 13. [Sterility control in drugs of biological origin].
    Kindt H; Körner L
    Arzneimittelforschung; 1969 Feb; 19(2):208-13. PubMed ID: 5818760
    [No Abstract]   [Full Text] [Related]  

  • 14. Some problems associated with sterility testing in a commercial organization.
    Gasson AG
    Dev Biol Stand; 1974; 23():151-6. PubMed ID: 4459189
    [No Abstract]   [Full Text] [Related]  

  • 15. New challenges in assuring vaccine quality.
    Dellepiane N; Griffiths E; Milstien JB
    Bull World Health Organ; 2000; 78(2):155-62. PubMed ID: 10743279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and testing of streptococcal M-antisera.
    Smith TB
    Z Immunitatsforsch Exp Klin Immunol; 1971 Jun; 141(5):430-40. PubMed ID: 4253489
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the relevance of the target animal safety test for the quality control of veterinary immunological medicinal products.
    Pöbetanecker A; Cubetaler K
    ALTEX; 1998; 15(5):71-75. PubMed ID: 11178548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO Expert Committee on Biological Standardization.
    Horowitz B; Minor P; Morgenthaler JJ; Burnouf T; McIntosh R; Padilla A; Thorpe R; van Aken WG;
    World Health Organ Tech Rep Ser; 2004; 924():1-232, backcover. PubMed ID: 15693660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological standards and pharmacopoeias.
    Perkins FT
    Ann Ist Super Sanita; 1975; 11(3-4):322-32. PubMed ID: 1234734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of PCR for extranous agent testing in avian vaccines.
    Ottiger HP
    Dev Biol (Basel); 2002; 111():23-6. PubMed ID: 12678221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.